BioCentury
ARTICLE | Company News

Mylan sales and marketing update

March 5, 2012 8:00 AM UTC

Mylan launched a generic version of escitalopram to treat major depressive disorder (MDD) and acute general anxiety disorder (GAD). Forest Laboratories Inc. (NYSE:FRX, New York, N.Y.) markets escital...